(3.27)--阿尔茨海默病中的淀粉样蛋白毒性.pdf
《(3.27)--阿尔茨海默病中的淀粉样蛋白毒性.pdf》由会员分享,可在线阅读,更多相关《(3.27)--阿尔茨海默病中的淀粉样蛋白毒性.pdf(15页珍藏版)》请在淘文阁 - 分享文档赚钱的网站上搜索。
1、Rev.Neurosci.2018;aopAllison B.Reiss*,Hirra A.Arain,Mark M.Stecker,Nicolle M.Siegart and Lora J.KasselmanAmyloid toxicity in Alzheimers diseaseAbstract:A major feature of Alzheimers disease(AD)pathology is the plaque composed of aggregated amyloid-(A)peptide.Although these plaques may have harmful p
2、roperties,there is much evidence to impli-cate soluble oligomeric A as the primary noxious form.A oligomers can be generated both extracellularly and intracellularly.A is toxic to neurons in a myriad of ways.It can cause pore formation resulting in the leakage of ions,disruption of cellular calcium
3、balance,and loss of membrane potential.It can promote apoptosis,cause synaptic loss,and disrupt the cytoskeleton.Current treat-ments for AD are limited and palliative.Much research and effort is being devoted to reducing A production as an approach to slowing or preventing the development of AD.A fo
4、rmation results from the amyloidogenic cleavage of human amyloid precursor protein(APP).Reconfigur-ing this process to disfavor amyloid generation might be possible through the reduction of APP or inhibition of enzymes that convert the precursor protein to amyloid.Keywords:amyloid oligomers;apolipop
5、rotein E;mito-chondria;oxidative stress;synapse.IntroductionAlzheimers disease(AD)is a chronic neurodegenerative disorder and the most common cause of gradually pro-gressive cognitive and functional decline in the elderly,accounting for 6080%of all dementias(Barnes and Yaffe,2011).A growing populati
6、on of older adults is expected to bring a rapid increase in the number of patients with AD.The toll on the quality of life is augmented by the lack of effective treatments.Brains of AD patients exhibit cortical atrophy result-ing from massive neuronal loss.As the major component of senile plaques,am
7、yloid-(A)peptide is considered as a crucial factor underlying neuronal and synaptic dysfunction in the progression of AD.Among its destruc-tive actions,A disrupts synaptic plasticity,inhibits hippocampal long-term potentiation(LTP;a form of syn-aptic plasticity that is thought to underlie learning a
8、nd memory),and induces the production of reactive oxygen species(ROS;Lustbader etal.,2004;Malenka and Bear,2004;Chang etal.,2006).This review focuses on the state of our rapidly evolv-ing knowledge of the various aspects of amyloid neu-rotoxicity.Amyloid species,cellular localization,and interaction
9、 with channels,receptors,and the synapse are all considered.We consider interactions between apolipo-proteins and amyloid as well as the role of microglia in amyloid clearance.Toxic amyloid:oligomers or mature fibrilsThe aggregation and accumulation of A peptide in the brain is a pathologic hallmark
10、 of AD.Amyloid monomers are derived from the larger amyloid precursor protein(APP)that is present on the surfaces of many cells,including neurons.In the pathway to A formation,APP undergoes proteolysis by-secretase,the-site APP cleaving enzyme 1(BACE1),and-secretase to form A fragments(Rossner etal.
11、,2006;Figure 1).There are two major species of A in the brain:A42 and A40.Although A40 is several-fold more abundant than A42 in soluble form,A42 is the major constituent of amyloid plaques(Jan etal.,2008).The process of fibrillogenesis begins with amyloid monomers that assemble to form a variety of
12、 oligomeric species that aggregate further to form short,flexible,irreg-ular protofibrils then ultimately mature and elongate into insoluble fibrils characterized by a repeating substruc-ture of-strands oriented perpendicularly to the fiber axis.Once A aggregates extracellularly to form fibrils,it b
13、ecomes resistant to proteolytic cleavage.A mono-mers exist in a dynamic equilibrium of a variety of con-formations with the-sheet form capable of aggregating to oligomers and higher structures.Initially,A40,or the even more aggregation-prone A42,misfolds then aggre-gates with other monomers to form
14、unstable soluble A oligomers(Walsh and Selkoe,2007).Oligomeric amyloid is an intermediate step in the formation of mature fibrils.*Corresponding author:Allison B.Reiss,Winthrop Research Institute,NYU Winthrop Hospital,101 Mineola Boulevard,Mineola,NY 11501,USA,e-mail:AReissNYUWinthrop.orgHirra A.Ara
15、in,Mark M.Stecker,Nicolle M.Siegart and Lora J.Kasselman:Winthrop Research Institute,NYU Winthrop Hospital,101 Mineola Boulevard,Mineola,NY 11501,USABrought to you by|Kings College LondonAuthenticatedDownload Date|5/22/18 6:47 PM2A.B.Reiss etal.:Amyloid toxicity in Alzheimers diseaseElectron microsc
16、opy showed that the minimal portion of A peptide sufficient to form fibrils is the 1423 decapep-tide,with residues 1721 involved in-sheet formation(Tjernberg etal.,1999;Bu etal.,2007).Amyloid fibrils accumulate and deposit in extracellular plaques,a hall-mark of AD.The relative toxicity of fibrillar
17、 versus oligomeric amyloid is an area of controversy.The size of the soluble amyloid that is most damaging(dimers,trimers,or larger)is an area of active investigation(Bao etal.,2012).Research suggests some toxicity from each species,although a growing consensus has formed for the greater toxicity of
18、 amyloid oligomers(Cleary etal.,2005).There remains,however,some divide in the research community regard-ing the main type of amyloid that is toxic.Here,we will summarize studies on the toxicity of both physical confor-mations of amyloid in human and animal systems.Although monomeric A at physiologi
19、c concentrations appears to be nontoxic,multiple lines of evidence point to low molecular weight oligomers rather than fibrils as the primary neurotoxic agents in AD(Glabe,2008).Oligom-ers formed by A peptides may be most harmful because they interact with cell membranes,disrupting their integ-rity(
20、Stefani,2010).Stphan etal.(2001)injected amyloid peptides into the rat dorsal dentate gyrus and found significant impairment in synaptic transmission,cogni-tive decline,and cell death only when an aggregation of amyloid occurred.The toxicity of A peptides correlated well with their propensity to agg
21、regate.Monomeric A was not harmful to cells(Giuffrida etal.,2009).The microinjection of fibrillar A into the brains of aged rhesus monkeys has been found to cause a signifi-cant loss of neuronal cells and the activation of microglia at the site of injection(Geula etal.,1998).In a study of primate br
22、ain pathology,neuronal and axonal loss were observed in the vicinity of fibrillar plaques in the cere-bral cortex in aged rhesus monkeys and in humans with and without AD(Shah etal.,2010).Diffuse,nonfibrillar plaques were not associated with neuronal loss.Although the literature suggests that fibril
23、lar amyloid has cytotoxic properties,numerous studies have demon-strated that fibril burden does not directly correlate with cognitive decline and neuronal death(Benilova et al.,2012).The disease severity of AD has been correlated IntracellularExtracellularA oligomerA monomer-Secretase cleavageAPPLi
24、pid raftCCCCCCCCCCCCCCBACE-1-Secretase complexCleavageFigure 1:Schematic of APP processing and amyloid formation in lipid rafts.APP generates a nonamyloidogenic product when cleaved by-secretase.The sequential cleavage by BACE1 and-secretase generates predominantly an A40 protein fragment,but-secret
25、ase is somewhat imprecise and can cleave at more than one site,creating a slightly longer form,A42,510%of the time.Both species tend to misfold and aggregate,generating oligomers,but A42 is the more fibrillo-genic.Oligomers aggregate to form protofibrils and fibrils,forming plaques.An equilibrium ma
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 3.27 阿尔茨海默病 中的 淀粉 蛋白 毒性
限制150内